+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Veracyte Inc (VCYT) - Product Pipeline Analysis, 2020 Update

  • ID: 5240127
  • Company Profile
  • January 2021
  • 39 pages
  • GlobalData
  • Veracyte Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Endocyte Inc
  • GeneThera Inc
  • MORE
Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products comprise Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also provides percepta bronchial genomic classifier an assay to evaluate patients with lung nodules that are suspected for cancer. Veracyte offers genomic testing to other areas of substantial clinical need with diagnostic ambiguity. The company markets its afirma solutions through its sales force across in the US. It also commercializes its products in Brazil. Veracyte is headquartered in South San Francisco, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Veracyte Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Endocyte Inc
  • GeneThera Inc
  • MORE
Veracyte Inc Company Overview
  • Veracyte Inc Company Snapshot
  • Veracyte Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Veracyte Inc - Pipeline Analysis Overview
  • Veracyte Inc - Key Facts
  • Veracyte Inc - Major Products and Services
  • Veracyte Inc Pipeline Products by Development Stage
Veracyte Inc Pipeline Products Overview
  • Afirma - Risk of Recurrence
  • Afirma - Risk of Recurrence Product Overview
  • Afirma - Thyroid Cancer Staging/ Prognosis Test
  • Afirma - Thyroid Cancer Staging/ Prognosis Test Product Overview
  • Afirma Xpression Atlas - Pulmonology
  • Afirma Xpression Atlas - Pulmonology Product Overview
  • BronchoGen Test
  • BronchoGen Test Product Overview
  • Disease Diagnosis Device
  • Disease Diagnosis Device Product Overview
  • Envisia - Disease Progression Test
  • Envisia - Disease Progression Test Product Overview
  • Envisia - Rx Response Test
  • Envisia - Rx Response Test Product Overview
  • Nasal Swab Classifier - Lung Cancer
  • Nasal Swab Classifier - Lung Cancer Product Overview
  • nCounter Dx LymphMark Assay
  • nCounter Dx LymphMark Assay Product Overview
  • nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test
  • nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test Product Overview
  • Percepta Atlas
  • Percepta Atlas Product Overview
Veracyte Inc - Key Competitors

Veracyte Inc - Key Employees

Veracyte Inc - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • Veracyte Inc, Recent Developments
  • Sep 11, 2020: Veracyte announces initiation of consensus study exploring medical utility of multiple breast cancer genomic tests
  • Dec 04, 2019: Veracyte signs agreement for NanoString’s diagnostics platform
  • Nov 02, 2019: Veracyte announces new data that advance understanding of genomic alterations targeted by precision medicine therapies for thyroid cancer
  • Oct 30, 2019: Veracyte announces new data characterizing genomic alterations in thyroid cancer to be presented at 89th Annual Meeting of the American Thyroid Association
  • Oct 22, 2019: Veracyte announces third quarter 2019 financial results and business progress
  • Oct 22, 2019: Veracyte announces new clinical data showing first-ever noninvasive nasal swab test can enable early lung cancer detection and diagnosis
  • Oct 21, 2019: Veracyte announces clinical data demonstrating clinical validity and utility of Percepta Classifier in Lung Cancer Diagnosis when bronchoscopy results are inconclusive
  • Oct 21, 2019: Veracyte announces new data demonstrating that Envisia Genomic Classifier improves IPF Diagnosis
  • Oct 07, 2019: Veracyte to announce new clinical data for first noninvasive Nasal Swab Test to target early lung cancer detection at CHEST Annual Meeting 2019
  • Sep 11, 2019: Veracyte announces publication of clinical and analytical validation data for Afirma Xpression Atlas
Appendix
  • Methodology
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • Veracyte Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Veracyte Inc Pipeline Products by Equipment Type
  • Veracyte Inc Pipeline Products by Indication
  • Veracyte Inc, Key Facts
  • Veracyte Inc, Major Products and Services
  • Veracyte Inc Number of Pipeline Products by Development Stage
  • Veracyte Inc Pipeline Products Summary by Development Stage
  • Afirma - Risk of Recurrence - Product Status
  • Afirma - Risk of Recurrence - Product Description
  • Afirma - Thyroid Cancer Staging/ Prognosis Test - Product Status
  • Afirma - Thyroid Cancer Staging/ Prognosis Test - Product Description
  • Afirma Xpression Atlas - Pulmonology - Product Status
  • Afirma Xpression Atlas - Pulmonology - Product Description
  • BronchoGen Test - Product Status
  • BronchoGen Test - Product Description
  • Disease Diagnosis Device - Product Status
  • Disease Diagnosis Device - Product Description
  • Envisia - Disease Progression Test - Product Status
  • Envisia - Disease Progression Test - Product Description
  • Envisia - Rx Response Test - Product Status
  • Envisia - Rx Response Test - Product Description
  • Nasal Swab Classifier - Lung Cancer - Product Status
  • Nasal Swab Classifier - Lung Cancer - Product Description
  • nCounter Dx LymphMark Assay - Product Status
  • nCounter Dx LymphMark Assay - Product Description
  • nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test - Product Status
  • nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test - Product Description
  • Percepta Atlas - Product Status
  • Percepta Atlas - Product Description
  • Veracyte Inc, Key Employees
  • Veracyte Inc, Other Locations
  • Veracyte Inc, Subsidiaries
  • Glossary
List of Figures
  • Veracyte Inc Pipeline Products by Equipment Type
  • Veracyte Inc Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 3
  • Lifelines Neurodiagnostic Systems Inc
  • Kerma Medical Products Inc
  • GeneThera Inc
  • Endocyte Inc
Note: Product cover images may vary from those shown
Adroll
adroll